Other countries are also seeking to reduce their reliance on China for APIs, most notably the US

Other countries are also seeking to reduce their reliance on China for APIs, most notably the US

Reducing dependence on China would be prudent for India’s pharmaceutical industry, but it must be strategic

JULY 4, 2020 8:48:19 AM

In India, any decoupling from China must be strategic, with significant policy support, and it will take time for a paced indigenisation. An ad hoc or reactive decoupling could disrupt the production of a wide range of medicines which currently require ingredients from China.